Log In
Print this Print this

Erythropoietin receptor agonists

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionSmall molecule erythropoietin (EPO) receptor agonists
Molecular Target Erythropoietin (EPO)
Mechanism of ActionErythropoietin (EPO) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAnemia
Indication DetailsTreat anemia
Regulatory Designation
PartnerViking Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today